| Primary |
| Idiopathic Thrombocytopenic Purpura |
74.4% |
| Product Used For Unknown Indication |
8.5% |
| Thrombocytopenia |
5.5% |
| Autoimmune Thrombocytopenia |
2.9% |
| Myelodysplastic Syndrome |
1.2% |
| Drug Use For Unknown Indication |
1.1% |
| Prophylaxis |
1.1% |
| Hepatitis C |
0.9% |
| Hypertension |
0.9% |
| Immune Thrombocytopenic Purpura |
0.7% |
| Platelet Count Decreased |
0.5% |
| Aplastic Anaemia |
0.3% |
| Diabetes Mellitus |
0.3% |
| Pain |
0.3% |
| Constipation |
0.2% |
| Ill-defined Disorder |
0.2% |
| Iron Deficiency |
0.2% |
| Epistaxis |
0.2% |
| Evans Syndrome |
0.2% |
| Atrial Fibrillation |
0.2% |
|
| Death |
33.2% |
| Drug Ineffective |
10.1% |
| Platelet Count Decreased |
8.8% |
| Liver Disorder |
5.6% |
| Thrombocytopenia |
4.0% |
| Myelodysplastic Syndrome |
3.6% |
| Liver Function Test Abnormal |
3.4% |
| Platelet Count Increased |
3.2% |
| Pneumonia |
3.0% |
| Pulmonary Embolism |
3.0% |
| Thrombosis |
2.8% |
| Myocardial Infarction |
2.5% |
| Bone Marrow Reticulin Fibrosis |
2.3% |
| Haematological Malignancy |
2.2% |
| Hospitalisation |
2.2% |
| Sepsis |
2.2% |
| Disease Progression |
2.0% |
| Idiopathic Thrombocytopenic Purpura |
2.0% |
| Nausea |
2.0% |
| Rash |
1.9% |
|
| Secondary |
| Idiopathic Thrombocytopenic Purpura |
68.5% |
| Prophylaxis |
6.9% |
| Product Used For Unknown Indication |
4.2% |
| Hypertension |
2.3% |
| Cancer Pain |
2.1% |
| Gastritis Prophylaxis |
2.1% |
| Adenocarcinoma Pancreas |
1.6% |
| Haemorrhage Prophylaxis |
1.6% |
| Insomnia |
1.6% |
| Rheumatoid Arthritis |
1.6% |
| Chronic Hepatitis C |
1.4% |
| Gastric Ulcer |
1.1% |
| Constipation |
0.9% |
| Adrenal Insufficiency |
0.7% |
| Duodenal Ulcer |
0.7% |
| Rib Fracture |
0.7% |
| Diabetes Mellitus |
0.5% |
| Immune Thrombocytopenic Purpura |
0.5% |
| Osteoporosis |
0.5% |
| Anxiety |
0.4% |
|
| Liver Disorder |
16.9% |
| Anaemia |
12.1% |
| Myocardial Ischaemia |
9.7% |
| Blood Bilirubin Increased |
6.5% |
| Intracardiac Thrombus |
6.5% |
| Cerebral Infarction |
4.8% |
| Pulmonary Embolism |
4.8% |
| Myelofibrosis |
4.0% |
| Thrombocytopenia |
4.0% |
| White Blood Cell Count Increased |
4.0% |
| Haemoglobin Decreased |
3.2% |
| Neuroblastoma |
3.2% |
| Small Cell Lung Cancer Stage Unspecified |
3.2% |
| Ascites |
2.4% |
| Cerebral Haemorrhage |
2.4% |
| Haemorrhagic Infarction |
2.4% |
| Ileus Paralytic |
2.4% |
| Multi-organ Failure |
2.4% |
| Platelet Count Decreased |
2.4% |
| Platelet Count Increased |
2.4% |
|
| Concomitant |
| Idiopathic Thrombocytopenic Purpura |
31.5% |
| Hepatitis C |
27.4% |
| Prophylaxis |
6.9% |
| Hypertension |
5.3% |
| Product Used For Unknown Indication |
4.7% |
| Gastritis |
2.7% |
| Osteoporosis |
2.5% |
| Colorectal Cancer |
2.0% |
| Rheumatoid Arthritis |
1.8% |
| Gastrointestinal Haemorrhage |
1.7% |
| Diabetes Mellitus |
1.5% |
| Eating Disorder |
1.5% |
| Epilepsy |
1.5% |
| Thrombocytopenia |
1.5% |
| Gastric Ulcer |
1.4% |
| Multiple Myeloma |
1.4% |
| Colon Cancer Metastatic |
1.3% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Pain |
1.1% |
| Cardiac Failure |
1.0% |
|
| Thrombocytopenia |
12.7% |
| Liver Disorder |
10.6% |
| Platelet Count Decreased |
10.6% |
| Therapeutic Response Decreased |
9.0% |
| Bone Marrow Reticulin Fibrosis |
6.3% |
| Renal Impairment |
5.8% |
| White Blood Cell Count Decreased |
5.8% |
| Decreased Appetite |
4.2% |
| Drug Ineffective |
4.2% |
| Death |
3.2% |
| Dizziness |
3.2% |
| Rash |
3.2% |
| Weight Decreased |
3.2% |
| Anaemia |
2.6% |
| Biopsy Bone Marrow Abnormal |
2.6% |
| Haemoglobin Decreased |
2.6% |
| Hepatic Function Abnormal |
2.6% |
| Neutrophil Count Decreased |
2.6% |
| Urinary Tract Infection |
2.6% |
| Breast Cancer |
2.1% |
|
